APA

Davenport K. R., Smith C. A., Hofstetter H., Horn J. R. & Hofstetter O. (20170130). Site-directed immobilization of a genetically engineered anti-methotrexate antibody via an enzymatically introduced biotin label significantly increases the binding capacity of immunoaffinity columns. : Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Chicago

Davenport Kaitlynn R, Smith Christopher A, Hofstetter Heike, Horn James R and Hofstetter Oliver. 20170130. Site-directed immobilization of a genetically engineered anti-methotrexate antibody via an enzymatically introduced biotin label significantly increases the binding capacity of immunoaffinity columns. : Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Harvard

Davenport K. R., Smith C. A., Hofstetter H., Horn J. R. and Hofstetter O. (20170130). Site-directed immobilization of a genetically engineered anti-methotrexate antibody via an enzymatically introduced biotin label significantly increases the binding capacity of immunoaffinity columns. : Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

MLA

Davenport Kaitlynn R, Smith Christopher A, Hofstetter Heike, Horn James R and Hofstetter Oliver. Site-directed immobilization of a genetically engineered anti-methotrexate antibody via an enzymatically introduced biotin label significantly increases the binding capacity of immunoaffinity columns. : Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 20170130.